118 related articles for article (PubMed ID: 12082291)
41. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
[TBL] [Abstract][Full Text] [Related]
43. [Unusual risk factors for lymph node metastasis in cancer of the uterine cervix].
Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre Mdo R
Rev Assoc Med Bras (1992); 2007; 53(4):338-43. PubMed ID: 17823738
[TBL] [Abstract][Full Text] [Related]
44. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
45. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
Reich O; Tamussino K; Lahousen M; Pickel H; Haas J; Winter R
Gynecol Oncol; 2000 Mar; 76(3):331-5. PubMed ID: 10684706
[TBL] [Abstract][Full Text] [Related]
46. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
[TBL] [Abstract][Full Text] [Related]
47. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
48. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
[TBL] [Abstract][Full Text] [Related]
49. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
50. The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA.
Bleker OP; Ketting BW; van Wayjen-Eecen B; Kloosterman GJ
Gynecol Oncol; 1983 Aug; 16(1):56-62. PubMed ID: 6884831
[TBL] [Abstract][Full Text] [Related]
51. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer.
Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B
Gynecol Oncol; 2007 Nov; 107(2):310-5. PubMed ID: 17826822
[TBL] [Abstract][Full Text] [Related]
52. [The prognostic significance of DNA ploidy in laryngeal cancers].
Akçam MT; Akkaya A; Deveci S; Ongürü O; Gerek M; Ozkaptan Y
Kulak Burun Bogaz Ihtis Derg; 2002; 9(6):414-23. PubMed ID: 12499829
[TBL] [Abstract][Full Text] [Related]
53. [The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes].
Vavra N; Sevelda P; Seifert M; Timar J; Kudielka I; Kucera H
Strahlenther Onkol; 1992 Sep; 168(9):524-7. PubMed ID: 1411926
[TBL] [Abstract][Full Text] [Related]
54. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
55. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
56. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
57. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
58. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
59. Flow cytometric determination of the DNA content in transitional cell carcinoma of the bladder: predictability of ploidy with regard to pelvic lymph node metastasis.
Lee SE; Kim YK
Int J Urol; 1994 Sep; 1(3):232-6. PubMed ID: 7614381
[TBL] [Abstract][Full Text] [Related]
60. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
